The emergence of a new acute respiratory syndrome Coronavirus 2 (SARS‐CoV‐2), the
cause of the 2019‐nCOV disease (COVID‐19), has caused a pandemic and a global health …

Effective treatments specific for COVID-19 are still lacking. In the setting of passive
immunotherapies based on neutralizing antibodies (nAbs), randomized controlled trials of …

COVID-19 is characterized by a wide range of clinical manifestations that may become
severe by progressing towards acute respiratory distress syndrome and death [1]. After an …

COVID-19 is an acute respiratory syndrome caused by SARS-COV-2 which has now
become a huge pandemic worldwide. The immunopathogenesis of COVID-19 has been …

The emergence of the novel coronavirus in Wuhan, China, which causes severe respiratory
tract infections in humans (COVID-19), has become a global health concern. Most …

The coronavirus disease (COVID-19) pandemic has triggered precipitous entry of multiple
novel therapeutic candidates into clinical trials often without control groups, randomization …

In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged,
causing a global pandemic called COVID-19. Currently, there is no definitive treatment for …

The novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in
humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma …

Introduction Patients with primary or secondary immunodeficiency (PID or SID) face
increased insecurity and discomfort in the light of the COVID-19 pandemic, not knowing if …

Since late 2019, the new SARS-CoV-2 virus belonging to the Coronaviridae family has been
responsible for COVID-19 pandemic, a severe acute respiratory syndrome. Several antiviral …